Taloporfin (Laserphyrin)
Revision as of 00:06, 10 June 2023 by Jwarner (talk | contribs) (→History of changes in PMDA indication)
Photosensitizer
Diseases for which it is used
History of changes in PMDA indication
- 2013-09-20: new additional indication and a new dosage for the treatment of primary malignant brain tumor (only for the case where surgical excision of tumor is performed).
- 2015-05-26: new additional indication for the treatment of recurrent esophageal cancer associated with local persistence after chemoradiotherapy or radiotherapy.